Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

ket which would adversely affect our business. We may be found noncompliant with applicable federal, state or international laws, rules or regulations which could result in fines and/or product recalls or otherwise cause us to expend significant resources to correct such non-compliance.

A small number of customers accounts for a large portion of our sales and the loss of one of them, or changes in their purchasing patterns, could result in substantially reduced sales, substantially and adversely impacting our financial results. If third-party payors do not adequately reimburse patients for our products, doctors may not prescribe them.

We rely on operational data obtained from IMS, an industry accepted data source. IMS data may not accurately reflect actual prescriptions (for instance, we believe IMS data does not capture all product prescriptions from some non-retail channels).

Our business and products are highly regulated; the regulatory status of some of our products makes these products subject to increased competition and other risks; and we run the risk that we, or third parties on whom we rely, could violate the governing regulations.

Some unforeseen difficulties may occur.

The above are some of the principal factors that could cause actual results to differ materially from those described in the forward-looking statements included above. These factors are not intended to represent a complete list of all risks and uncertainties inherent in our business, and should be read in conjunction with the more detailed cautionary statements and risk factors included in our other filings with the Securities and Exchange Commission.

CONTACT: Sciele Pharma, Inc.
Joseph T. Schepers, 678-341-1401
ir@sciele.com



'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:8/22/2014)... DUBLIN , August 22, 2014 ... of Hospital TVs Today Lincor announced general ... Patient Engagement solution that delivers a range of education, ... sets.      (Logo: http://photos.prnewswire.com/prnh/20140822/702945) , ... in defining point of care patient engagement to bedside ...
(Date:8/22/2014)... Aug. 22, 2014  Landauer, Inc. (NYSE: ... radiation measurement and monitoring, outsourced medical physics services and ... William E. Saxelby , its President and Chief Executive ... Executive Officer and as a member of the Board ... will be replaced on an interim basis by ...
(Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: ... offering of units of common stock and warrants at ... of $20 million, prior to deducting underwriting discounts and ... shares and warrants are immediately separable and will be ... to begin trading on The NASDAQ Stock Market under ...
Breaking Medicine Technology:Lincor Unveils Next Generation TV-based Patient Engagement Solution 2Landauer, Inc. Announces Executive Management Change 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... MONMOUTH JUNCTION, N.J., March 29, 2011 Tris Pharma, ... anticipated re-launch of the MyKidz® Iron product ... has attracted a loyal following of pediatricians, pediatric nurses ... its product pipeline in a different direction, availability of ...
... NEW YORK, March 29, 2011 Reportlinker.com announces that a ... Top 150 Antibiotic Manufacturers (Global) ... Industry Report Plimsoll Publishing Ltd. Do ... in the industry? Which company has the highest ...
Cached Medicine Technology:Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements 2Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements 3Reportlinker Adds Top 150 Antibiotic Manufacturers (Global) 2Reportlinker Adds Top 150 Antibiotic Manufacturers (Global) 3Reportlinker Adds Top 150 Antibiotic Manufacturers (Global) 4
(Date:8/23/2014)... Teen substance abuse ranks as one of the most ... adolescents throughout North Carolina struggle with a drug or alcohol ... professional rehab due to a lack of information available to ... Teens Holly Springs is a helpline designed to make a ... abusers in Wake County who are seeking to overcome ...
(Date:8/22/2014)... August 23, 2014 2014 Deep ... a professional and in-depth research report on the ... Meter information, including Glucose Meter definition, classification, application, ... overview. This research covers the international market analysis, ... analysis covering macroeconomic environment & economic situation analysis. ...
(Date:8/22/2014)... August 22, 2014 AWeber, one ... that currently helps more than 120,000 small businesses ... the attention of Shane Michaels, prompting an investigative review. ... element for any online marketing campaign, despite what some ... the marketing world,” reports Michaels. “AWeber is a great ...
(Date:8/22/2014)... This report studies the "Sample Preparation Market by ... Kits (Isolation, Purification), By Application (Genomics, Proteomics), by ... 2018" This market was valued at $4,254.8 million ... a CAGR of 5.9% from 2013 to 2018, ... 98 market data Tables and 23 Figures spread ...
(Date:8/22/2014)... Millennium Treatment Group has recently noticed an ... level of drug use among teenagers. The treatment facility aims ... and work to minimize drug abuse. , America is currently ... addiction in history. According to the National Institute of ... aged 12 or older—or 9.2 percent of the population—had used ...
Breaking Medicine News(10 mins):Health News:New Helpline Provides Teen Drug & Alcohol Recovery Information in Holly Springs, NC 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... management solutions , today announced that Premier Inc. has selected ... , ... Jacksonville, FL (PRWEB) July ... compensation management solutions , today announced that Premier Inc. has ...
... years of education, completing specialized training and practicing medicine in fields ... College at Indiana University of Pennsylvania influence and enhance their chosen ... ... (PRWEB) July 16, 2008 -- Each day brings patients with different ...
... VendorClear™, the company who pioneered web-based vendor access services for ... and vendor representatives operate more efficiently and increase facility safety. ... ... July 16, 2008 -- VendorClear™, the company who pioneered web-based ...
... health professionals from across the country will convene July ... and policy issues faced by public health officials and ... , "Confronting the Ethics of Pandemic Influenza Planning: ... the Indiana State Department of Health, the Indiana University ...
... in America for Over 26,Million Americans Suffering from ... WASHINGTON, July 15 In response to today,s,passage ... Partners (KCP) -- an,alliance of patient advocates, dialysis ... quality of care for individuals,with kidney disease and ...
... Quality through National E-Prescribing, ... AARP ... DESKS: AARP,is recording House and Senate roll call votes on key issues ... results,of these key votes., , SUMMARY: Today the U.S. House of ...
Cached Medicine News:Health News:Premier Inc Automates their Compensation Management Processes, Chooses HCR Software's CompensationXL Product 2Health News:Premier Inc Automates their Compensation Management Processes, Chooses HCR Software's CompensationXL Product 3Health News:Premier Inc Automates their Compensation Management Processes, Chooses HCR Software's CompensationXL Product 4Health News:Robert E Cook Honors College Women In Medicine 2Health News:Robert E Cook Honors College Women In Medicine 3Health News:Robert E Cook Honors College Women In Medicine 4Health News:Robert E Cook Honors College Women In Medicine 5Health News:Robert E Cook Honors College Women In Medicine 6Health News:VendorClear™ Introduces Revolutionary Products for Healthcare Facilities and Vendor Representatives 2Health News:Confronting Ethics of Pandemic Influenza Planning: 2008 Summit of the States 2Health News:Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease (ESRD) Reform 2Health News:AARP Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 2Health News:AARP Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 3
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements....
... Thinsite is designed using sophisticated lathing ... concepts. Thinsite lenses feature a center thickness ... ranges. While all plus powered Thinsite lenses ... over standard designs. The unique design eliminates ...
An easy-to-fit RGP daily wear lens with a unique bi-aspheric back surface design that provides excellent patient comfort and adaptation. Boston Envision contact lenses are an ideal alternative for vi...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
Medicine Products: